Agomelatine-induced liver injury in a patient with choledocholithiasis.
CONCLUSIONS: It is hypothesized that choledocholithiasis could theoretically increase a risk of developing agomelatine-induced hepatotoxicity in this patient. Any pre-existing liver disease should be a contraindication for treatment with agomelatine.
PMID: 25335994 [PubMed - as supplied by publisher]
Source: Acta Neuropsychiatrica - Category: Psychiatry Tags: Acta Neuropsychiatr Source Type: research
More News: Bile | Depression | Gallstones | Gastroenterology | Liver | Liver Disease | Neurology | Psychiatry | Urology & Nephrology